Biologics and cell therapy programs are under increasing pressure to deliver high‑quality cell lines and physiologically meaningful 3D models—faster, more consistently, and with full traceability. Yet ...

From changing media to assay execution, compact automated tools help researchers perform efficient and reliable cellular experiments.

Cell and gene therapy (CGT) manufacturers can struggle to move from lab-scale to clinical-scale production. Automation can help but, to make a success of the transition, developers must be willing to ...

A novel approach to automating cell therapy manufacturing using industry-standard equipment can potentially reduce human errors, deliver higher quality product, and lower manufacturing costs by ...

As non-animal models move mainstream, the focus is shifting toward reproducibility and data integrity. By using specialized ...

Discovery of efficient anti-cancer drugs and drug combinations is essential for therapy success. Therefore, it is crucial that new methods for efficient drug efficacy testing are developed to support ...

LAWRENCEBURG, Tenn., March 11, 2026 /PRNewswire/ -- DRM, LLC, a Tennessee-based automation integrator, OEM equipment builder and general contractor, will exhibit at the MAX Manufacturing and ...

This article and associated images are based on a poster originally authored by Wambeke E, Boribong BP, Sinha H, Patel M, Vo PQN, Chin AB, Ellouzi A, Barlan K and Hirukawa A and presented at ELRIG ...

CAMBRIDGE, England & STEVENAGE, England--(BUSINESS WIRE)--Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and ...

Engineers have created new technology that can move cells without touching them, enabling critical tasks that currently require large pieces of lab equipment to be carried out on a benchtop device.